Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.61 |
| ▸ | PKM | P14618 | 1/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.59 |
| ▸ | POLB | P06746 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | LTA4H | P09960 | 1/20 | 0.52 |
| ▸ | IDO1 | P14902 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.47 |
| ▸ | GPR52 | Q9Y2T5 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.45 |
| ▸ | HTR2C | P28335 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11751719 | 0.87 | ATM (0.60) | LMNAPKMHSD17B10ALDH1A1LTA4H | |
| SCHEMBL11754092 | 0.85 | LMNA (0.57) | LMNAPKMHSD17B10ALDH1A1POLB | |
| SCHEMBL11750621 | 0.85 | LMNA (0.57) | LMNAPKMHSD17B10ALDH1A1POLB | |
| SCHEMBL11749002 | 0.84 | ALDH1A1 (0.53) | LMNAPKMHSD17B10ALDH1A1POLB | |
| SCHEMBL3467136 | 0.81 | ALDH1A1 (0.63) | LMNAPKMHSD17B10ALDH1A1POLB | |
| SCHEMBL21384242 | 0.80 | ALDH1A1 (0.65) | LMNAALDH1A1POLBHTTIDO1 | |
| SCHEMBL11750879 | 0.79 | ALDH1A1 (0.56) | LMNAPKMHSD17B10ALDH1A1POLB | |
| Hydrochloric Acid SCHEMBL14109465 | 0.78 | IDO1 (0.51) | LMNAPKMHSD17B10LTA4HIDO1 | |
| SCHEMBL14108792 | 0.77 | GPR52 (0.51) | LTA4HIDO1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL605184 | 0.77 | ALDH1A1 (0.66) | LMNAALDH1A1POLBHTTIDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-3965110-A | 2-Amino-5-(trifluoromethyl phenylalkyl)-1,3,4-thiadiazoles | SANDOZ, INC. (US) | 1976-06-22 | — | — | US | claimed |
| WO-2010073011-A2 | COMPOUNDS USEFUL AS MEDICAMENTS | BETAGENON AB (SE) | 2010-07-01 | — | — | WO | disclosed |
| US-20100158996-A1 | ESTER COMPOUND AND MEDICAL USE THEREOF | JAPAN TOBACCO INC. | 2010-06-24 | — | — | US | disclosed |
| US-20100120669-A1 | THIADIAZOLE DERIVATIVES, INHIBITORS OF STEAROYL-COA DESATURASE | BOUILLOT ANNE MARIE JEANNE | 2010-05-13 | — | — | US | disclosed |
| US-7625948-B2 | Ester compound and medicinal use thereof | JAPAN TOBACCO INC. (JP) | 2009-12-01 | — | — | US | disclosed |
| US-20050075367-A1 | Ester compound and medicinal use thereof | JAPAN TOBACCO INC. (JP) | 2005-04-07 | — | — | US | disclosed |
| EP-1479666-A1 | ESTER COMPOUND AND MEDICINAL USE THEREOF | JAPAN TOBACCO INC. (JP) | 2004-11-24 | — | — | EP | disclosed |
| US-4054665-A | 2-Amino-5-(trifluoromethylphenylalkyl)-1,3,4 thiadiazoles used in the treatment of insomnia and anxiety | SANDOZ, INC. (US) | 1977-10-18 | — | — | US | disclosed |
| US-4054665-A | 2-Amino-5-(trifluoromethylphenylalkyl)-1,3,4 thiadiazoles used in the treatment of insomnia and anxiety | SANDOZ, INC. (US) | 1977-10-18 | — | — | US | disclosed |
| US-3965110-A | 2-Amino-5-(trifluoromethyl phenylalkyl)-1,3,4-thiadiazoles | SANDOZ, INC. (US) | 1976-06-22 | — | — | US | disclosed |
| US-3965110-A | 2-Amino-5-(trifluoromethyl phenylalkyl)-1,3,4-thiadiazoles | SANDOZ, INC. (US) | 1976-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050075367-A1 | Ester compound and medicinal use thereof | LIPC, CES1, MTTP | LMNA 2248/4885PKM 1527/4885HSD17B10 54/4885 |
| US-20100120669-A1 | THIADIAZOLE DERIVATIVES, INHIBITORS OF STEAROYL-COA DESATURASE | SCD, SCD5, FADS2 | LMNA 2761/4885PKM 1419/4885HSD17B10 24/4885 |
| US-20100158996-A1 | ESTER COMPOUND AND MEDICAL USE THEREOF | LIPC, CES1, MTTP | LMNA 2365/4885PKM 1650/4885HSD17B10 58/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.